Ritalin and Hypothermia - a phase IV clinical study of FDA data
Summary:
Hypothermia is reported as a side effect among people who take Ritalin (methylphenidate hydrochloride), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Halcion, and have Ill-defined disorder.
The phase IV clinical study analyzes which people have Hypothermia when taking Ritalin. It is created by eHealthMe based on reports of 26,179 people who have side effects when taking Ritalin from the FDA, and is updated regularly.
What is Ritalin?
Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.
What is Hypothermia?
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions) is found to be associated with 776 drugs and 997 conditions by eHealthMe. Check the latest studies of Hypothermia.
26,179 people reported to have side effects when taking Ritalin.
Among them, 22 people (0.08%) have Hypothermia.

Among these 22 people:
How long have people been on Ritalin when they have Hypothermia? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hypothermia when taking Ritalin? *
- female: 22.73 %
- male: 77.27 %
What is the age of people who have Hypothermia when taking Ritalin? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 30 %
- 20-29: 35 %
- 30-39: 30 %
- 40-49: 5 %
- 50-59: 0.0 %
- 60+: 0.0 %
What are other drugs people take besides Ritalin? *
- Halcion: 11 people, 50.00%
- Anafranil: 5 people, 22.73%
- Perphenazine: 5 people, 22.73%
- Concerta: 4 people, 18.18%
- Luvox: 4 people, 18.18%
- Morphine: 3 people, 13.64%
- Prinivil: 3 people, 13.64%
- Mellaril: 3 people, 13.64%
- Zantac: 3 people, 13.64%
- Motrin: 3 people, 13.64%
What are other side effects people have besides Hypothermia? *
- Cardiac Arrest: 7 people, 31.82%
- Pancreatitis Acute (sudden inflammation of pancreas): 6 people, 27.27%
- Mydriasis (a dilation of the pupil): 6 people, 27.27%
- Stupor (lack of critical cognitive function and level of consciousness): 6 people, 27.27%
- Pancreatic Pseudocyst (collection of tissue and fluids that forms on pancreas): 6 people, 27.27%
- Gamma-Glutamyltransferase Increased: 5 people, 22.73%
- Drowsiness: 5 people, 22.73%
- Suicide Attempt: 5 people, 22.73%
- Loss Of Consciousness: 5 people, 22.73%
- Speech Disorder: 5 people, 22.73%
What are the existing conditions these people have? *
- Ill-Defined Disorder: 6 people, 27.27%
- Diabetes: 2 people, 9.09%
- Suicide Attempt: 1 person, 4.55%
- Rickets (softening of bones): 1 person, 4.55%
- Poisoning Deliberate: 1 person, 4.55%
- Mood Swings (an extreme or rapid change in mood): 1 person, 4.55%
- Concussion (short loss of normal brain function in response to a head injury): 1 person, 4.55%
- Completed Suicide (act of taking one's own life): 1 person, 4.55%
- Affective Disorder (mental disorder): 1 person, 4.55%
* Approximation only. Some reports may have incomplete information.
Do you take Ritalin and have Hypothermia?
- Check whether Hypothermia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ritalin:
- Ritalin (29,427 reports)
Hypothermia treatments and more:
- Hypothermia (12,298 reports)
How severe was Hypothermia and when was it recovered:
Expand to all the drugs that have ingredients of methylphenidate hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ritalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hypothermia:
- Hypothermia (776 drugs)
Browse all the conditions that are associated with Hypothermia:
- Hypothermia (997 conditions)
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Ritalin) and Ritalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Stress And Anxiety and drugs of ingredients of tolvaptan - 4 seconds ago
- Xenical and Gallstones for Women aged 30-39 - 8 seconds ago
- Xenical and Cholelithiasis for Women aged 30-39 - 9 seconds ago
- Atomoxetine and Tremors for Boys aged 10-19 - 11 seconds ago
- Atomoxetine and Tremor for Boys aged 10-19 - 11 seconds ago
- Could Actemra cause Furuncle? - 12 seconds ago
- Tylenol and Pericarditis for Women aged 40-49 - 15 seconds ago
- Aleve and Slurred Speech for Women aged 60+ - 15 seconds ago
- Aleve and Language Impairment for Women aged 60+ - 15 seconds ago
- Aleve and Inability To Speak for Women aged 60+ - 15 seconds ago